HeraMED Limited (FRA:1I4)

HeraMED Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22	10	5	19	29	10
Market Cap Growth	128.24%	120.14%	-75.35%	-33.21%	177.48%	0.68%
Enterprise Value	22	10	4	18	27	9
Last Close Price	0.02	0.01	0.04	0.07	0.13	0.06
PS Ratio	123.78	48.07	12.72	94.17	379.07	322.22
PB Ratio	69.39	6.32	11.24	7.20	-309.93	6.37
P/TBV Ratio	69.39	6.32	11.24	7.20	-	6.69
EV/Sales Ratio	119.66	44.74	11.10	86.59	357.97	264.13
Debt / Equity Ratio	-	0.03	0.38	0.06	-32.25	0.10
Asset Turnover	0.14	0.10	0.13	0.05	0.02	0.01
Inventory Turnover	0.38	0.40	0.79	0.60	0.54	0.50
Quick Ratio	2.33	3.12	0.95	3.43	0.88	3.85
Current Ratio	3.04	3.52	1.28	3.85	0.94	4.28
Return on Equity (ROE)	-518.37%	-317.64%	-277.44%	-354.24%	-603.42%	-153.16%
Return on Assets (ROA)	-105.38%	-91.62%	-92.11%	-45.46%	-63.26%	-63.45%
Return on Capital (ROIC)	-253.83%	-179.33%	-154.21%	-62.60%	-89.49%	-89.52%
Return on Capital Employed (ROCE)	-370.60%	-158.90%	-460.60%	-94.50%	-888.70%	-128.80%
Earnings Yield	-11.34%	-31.35%	-87.87%	-23.67%	-17.38%	-26.38%
FCF Yield	-9.99%	-27.49%	-74.11%	-12.44%	-9.90%	-21.86%
Buyback Yield / Dilution	-145.72%	-104.14%	-21.65%	-22.61%	-38.84%	-42.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.